Tremor ve Diğer Hareket Bozukluklarına Yaklaşım
Özet
Tremor (titreme), distoni, kore, miyoklonus ve huzursuz bacaklar sendromu gibi çeşitli hareket bozukluklarının klinik özelliklerini, etiyolojilerini ve tedavi yaklaşımlarını detaylı bir şekilde ele almaktadır. En yaygın görülen hareket bozukluğu olan esansiyel tremor ile Parkinson hastalığı tremoru arasındaki farklar vurgulanırken, tanı sürecinde hastanın öyküsü ve nörolojik muayenesinin kritik önemi belirtilmektedir. Tedavi seçenekleri arasında medikal ilaçlar, botulinum toksin uygulamaları ve cerrahi müdahaleler yer alsa da, bozuklukların türüne göre tedavi etkinliğinin değişkenlik gösterdiği ifade edilmektedir.
This part provides a detailed analysis of various movement disorders such as tremor, dystonia, chorea, myoclonus, and restless legs syndrome, covering their clinical features, etiologies, and treatment approaches. It emphasizes the differences between essential tremor, the most common movement disorder, and Parkinsonian tremor, highlighting the critical importance of patient history and neurological examination in diagnosis. While treatment options include medical medications, botulinum toxin applications, and surgical interventions, the effectiveness of these treatments varies depending on the specific type of disorder.
Referanslar
Smaga S. Tremor. Am Fam Physician 2003;68: 1545-53.
Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010; 25:534-41.
Louis ED, Ford B, Frucht S, et al. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 2001; 49: 761-9.
Deng H, Le W, Jankovic J. Genetics of essential tremor.Brain 2007;130:1456-1464.
Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet. 2009;41:277-279.
Deuschl G, Elble RJ. The pathophysiology of essential tremor. Neurology,2000;54:14-20
Louis ED, Dogu O. Isolated head tremor: part of the clinical spectrum of essential tremor? Data from population-based and clinic-based case samples. Mov Disord. 2009;24:2281-2285.
Schrag A, Munchau A, Bhatia KP, et al. Essential tremor: an overdiagnosed condition? J Neurol 2000; 247: 955-9.
Deuschl G, Bain P, Brin M, et al. Scientifi c Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998; (13 Suppl 3): 2-23
Zesiewicz TA, Chari A, Jahan I, et al. Overview of essential tremor. Neuropsychiatr Dis Treat 2010; 6: 401-8
Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: Therapies for essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64: 2008-20
Brin MF, Lyons KE, Doucette J, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001; 56: 1523-28.
Jankoviç J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-376
Watts RL, Koller WC. Movement disorders. Neurologic Principles and Practice, McGraw Hill New York (1997) pp.780
León J, Louis ED, Bermejo-Pareja F. Neurological Disorders in Central Spain Study Group. J Neurol Neurosurg Psychiatry 2009; 80:423-5 17.
Geraghty JJ, Jankovic J, Zetusky WJ. (Association between essential tremor and Parkinson’s disease. Ann Neurol, 1985;17:329-33 18.
Lang AE, Kierans C, Blair RD. Association between familial tremor and Parkinson's disease. Ann Neurol, 1986;19: 306-7.
Danek A. Geniospazm:hereditary chin trembling. Mov Disord 1993;8:335-338.
Lefebre-D’Amour M, Shahani BT, Young RR. Tremor in alcoholic patients. Prog Clin Neurophisiol 1978;5:160-164.
Hartmann A, Pogarell O, Oertel WH. Sekondary dystonia. J Neurol 1998;245:511-518.
Janavs J, Aminoff MJ. Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 1998;65:436-445.
Cardoso F, Silva CE, Mota CC. Sydenham’s chorea in 50 consecuyive patients with rheumatic fever. Mov Disord 1997;12:701-703.
Chu K, Kang DW, Kim DE et al.diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hiperviscosity syndrome. Arch Neurol 2002;59:448-452.
Kalita J, Ranjan P, Misra UK, Das BK. Hemichorea: a rare presentation of tuberculoma. J Neurol Sci 2003;208:109-111.
Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs. 2002b;16:663-668.
Caviness JN, Brown P. Myoclonus: current concepts and recent advances. The Lancet Neurology 2004; 3: 598-607.
Fahn S. Overview, history, and classification of myoclonus. In: Fahn S, Hallet M, Frucht SJ, Truong DD editors. Advances in Neurolgy. 1st ed. Philadelphia: Lippincott Williams and Wilkins;2002 p13- 17.
Gorman KM, King MD. Footloose: Spinal Myoclonus after Myelomeningocele Repair. The Journal of pediatrics 2016; 173: 261-. e1.
Warren JE, Vidailhet M, Kneebone CS, Quinn NP, Thompson PD. Myoclonus in spinal dysraphism. Movement disorders 2003; 18: 961-4.
Klockgether T. Ataxias. In Goetz C, Textbook of Clinical Neurology. 3rd ed, New York: Saunders, 2007; Chapter 35,765-780.
Özbek ES, Çelebi Ö, Saka E. Tic Disorders, Tourette’s Syndrome and Treatment. Turkiye Klinikleri J Neurol Special Topics 2015; 8(2):51-6.
